相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Zinc transporter 5 and zinc transporter 7 induced by high glucose protects peritoneal mesothelial cells from undergoing apoptosis
Xiuli Zhang et al.
CELLULAR SIGNALLING (2013)
Dihydroartemisinin suppresses cell proliferation, invasion, and angiogenesis in human glioma U87 cells
Xiangrong Chen et al.
AFRICAN JOURNAL OF PHARMACY AND PHARMACOLOGY (2012)
Proteomic analysis shows the upregulation of erythrocyte dematin in zinc-restricted human subjects
Moon-Suhn Ryu et al.
AMERICAN JOURNAL OF CLINICAL NUTRITION (2012)
Antiproliferative effects of artemisinin on human breast cancer cells requires the downregulated expression of the E2F1 transcription factor and loss of E2F1-target cell cycle genes
Antony S. Tin et al.
ANTI-CANCER DRUGS (2012)
Dihydroartemisinin exhibits antitumor activity toward hepatocellular carcinoma in vitro and in vivo
Chris Zhiyi Zhang et al.
BIOCHEMICAL PHARMACOLOGY (2012)
Artesunate induces apoptosis via a Bak-mediated caspase-independent intrinsic pathway in human lung adenocarcinoma cells
Chenjuan Zhou et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2012)
3,5-Diaryl-2-aminopyridines as a Novel Class of Orally Active Antimalarials Demonstrating Single Dose Cure in Mice and Clinical Candidate Potential
Yassir Younis et al.
JOURNAL OF MEDICINAL CHEMISTRY (2012)
Coordinate expression and localization of iron and zinc transporters explain iron-zinc interactions during uptake in Caco-2 cells: implications for iron uptake at the enterocyte
Vasuprada Iyengar et al.
JOURNAL OF NUTRITIONAL BIOCHEMISTRY (2012)
Characterization of dihydroartemisinin-resistant colon carcinoma HCT116/R cell line
Jin-Jian Lu et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2012)
Bioinformatic and experimental fishing for artemisinin-interacting proteins from human nasopharyngeal cancer cells
T. Eichhorn et al.
MOLECULAR BIOSYSTEMS (2012)
LyP-1 Modification To Enhance Delivery of Artemisinin or Fluorescent Probe Loaded Polymeric Micelles to Highly Metastatic Tumor and Its Lymphatics
Zhaohui Wang et al.
MOLECULAR PHARMACEUTICS (2012)
Pharmacokinetics and pharmacodynamics of intravenous artesunate during severe malaria treatment in Ugandan adults
Pauline Byakika-Kibwika et al.
MALARIA JOURNAL (2012)
Dihydroartemisinin Enhances Apo2L/TRAIL-Mediated Apoptosis in Pancreatic Cancer Cells via ROS-Mediated Up-Regulation of Death Receptor 5
Rui Kong et al.
PLOS ONE (2012)
Histone Deacetylase Inhibitors Facilitate Dihydroartemisinin-Induced Apoptosis in Liver Cancer In Vitro and In Vivo
Chris Zhiyi Zhang et al.
PLOS ONE (2012)
Malarial dihydrofolate reductase as a paradigm for drug development against a resistance-compromised target
Yongyuth Yuthavong et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Interruption of the MEK/ERK signaling cascade promotes dihydroartemisinin-induced apoptosis in vitro and in vivo
Ning Gao et al.
APOPTOSIS (2011)
Dihydroartemisinin shift the immune response towards Th1, inhibit the tumor growth in vitro and in vivo
Shokoofe Noori et al.
CELLULAR IMMUNOLOGY (2011)
Artesunate enhances radiosensitivity of human non-small cell lung cancer A549 cells via increasing NO production to induce cell cycle arrest at G2/M phase
Yanyan Zhao et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2011)
Design of novel artemisinin-like derivatives with cytotoxic and anti-angiogenic properties
Shahid Soomro et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2011)
Structure-Guided Lead Optimization of Triazolopyrimidine-Ring Substituents Identifies Potent Plasmodium falciparum Dihydroorotate Dehydrogenase Inhibitors with Clinical Candidate Potential
Jose M. Coteron et al.
JOURNAL OF MEDICINAL CHEMISTRY (2011)
Artesunate inhibits growth and induces apoptosis in human osteosarcoma HOS cell line in vitro and in vivo
Qiang Xu et al.
JOURNAL OF ZHEJIANG UNIVERSITY-SCIENCE B (2011)
Review of the clinical pharmacokinetics of artesunate and its active metabolite dihydroartemisinin following intravenous, intramuscular, oral or rectal administration
Carrie A. Morris et al.
MALARIA JOURNAL (2011)
Artesunate mitigates proliferation of tumor cells by alkylating heme-harboring nitric oxide synthase
Qing-Ping Zeng et al.
NITRIC OXIDE-BIOLOGY AND CHEMISTRY (2011)
Artemisinin inhibits in vitro and in vivo invasion and metastasis of human hepatocellular carcinoma cells
Tan Weifeng et al.
PHYTOMEDICINE (2011)
Cytotoxic activity of secondary metabolites derived from Artemisia annua L. towards cancer cells in comparison to its designated active constituent artemisinin
Thomas Efferth et al.
PHYTOMEDICINE (2011)
Synthetic ozonide drug candidate OZ439 offers new hope for a single-dose cure of uncomplicated malaria
Susan A. Charman et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
p38 Mitogen-Activated Protein Kinase-Driven MAPKAPK2 Regulates Invasion of Bladder Cancer by Modulation of MMP-2 and MMP-9 Activity
Binod Kumar et al.
CANCER RESEARCH (2010)
Arterolane, a New Synthetic Trioxolane for Treatment of Uncomplicated Plasmodium falciparum Malaria: A Phase II, Multicenter, Randomized, Dose-Finding Clinical Trial
Neena Valecha et al.
CLINICAL INFECTIOUS DISEASES (2010)
Dihydroartemisinin can inhibit calmodulin, calmodulin-dependent phosphodiesterase activity and stimulate cellular immune responses
Shokoofe Noori et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2010)
Artesunate inhibiting angiogenesis induced by human myeloma RPMI8226 cells
Hao Chen et al.
INTERNATIONAL JOURNAL OF HEMATOLOGY (2010)
Growth inhibitory effects of dihydroartemisinin on pancreatic cancer cells: involvement of cell cycle arrest and inactivation of nuclear factor-κB
Hua Chen et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2010)
Artesunate versus quinine in the treatment of severe falciparum malaria in African children (AQUAMAT): an open-label, randomised trial
Arjen M. Dondorp et al.
LANCET (2010)
Dihydroartemisinin Induces Apoptosis by a Bak-Dependent Intrinsic Pathway
Rene Handrick et al.
MOLECULAR CANCER THERAPEUTICS (2010)
Pharmacogenomic Identification of c-Myc/Max-Regulated Genes Associated with Cytotoxicity of Artesunate towards Human Colon, Ovarian and Lung Cancer Cell Lines
Serkan Sertel et al.
MOLECULES (2010)
The Molecular Mechanism of Action of Artemisinin-The Debate Continues
Paul M. O'Neill et al.
MOLECULES (2010)
Pharmacokinetic Properties of Sulfadoxine-Pyrimethamine in Pregnant Women
Harin A. Karunajeewa et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2009)
VisANT 3.5: multi-scale network visualization, analysis and inference based on the gene ontology
Zhenjun Hu et al.
NUCLEIC ACIDS RESEARCH (2009)
Paclitaxel promotes a caspase 8-mediated apoptosis through death effector domain association with microtubules
A. Mielgo et al.
ONCOGENE (2009)
Heme Mediates Cytotoxicity from Artemisinin and Serves as a General Anti-Proliferation Target
Shiming Zhang et al.
PLOS ONE (2009)
Dihydroartemisinin induces apoptosis in human leukemia cells HL60 via downregulation of transferrin receptor expression
Hui-Jun Zhou et al.
ANTI-CANCER DRUGS (2008)
First assessment in humans of the safety, tolerability, pharmacokinetics, and ex vivo pharmacodynamic antimalarial activity of the new artemisinin derivative artemisone
Johannes Nagelschmitz et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2008)
Heme activates artemisinin more efficiently than hemin, inorganic iron, or hemoglobin
Shiming Zhang et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2008)
Characterization of the two major CYP450 metabolites of ozonide (1,2,4-trioxolane) OZ277
Lin Zhou et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2008)
Dihydroartemisinin induces apoptosis in HL-60 leukemia cells dependent of iron and p38 mitogen-activated protein kinase activation but independent of reactive oxygen species
Jin-Jian Lu et al.
CANCER BIOLOGY & THERAPY (2008)
Pyrimethamine induces apoptosis of melanoma cells via a caspase and cathepsin double-edged mechanism
Anna Maria Giammarioli et al.
CANCER RESEARCH (2008)
Dihydroartemisinin potentiates the cytotoxic effect of temozolomide in rat C6 glioma cells
Xiao-Jia Huang et al.
PHARMACOLOGY (2008)
Artemisinins: their growing importance in medicine
Sanjeev Krishna et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2008)
Differential expression of novel tyrosine kinase substrates during breast cancer development
Yunhao Chen et al.
MOLECULAR & CELLULAR PROTEOMICS (2007)
Pharmacokinetics of sulfadoxine-pyrimethamine in HIV-infected and uninfected pregnant women in western Kenya
Michael D. Green et al.
JOURNAL OF INFECTIOUS DISEASES (2007)
Role of Transferrin Receptor and the ABC Transporters ABCB6 and ABCB7 for Resistance and Differentiation of Tumor Cells towards Artesunate
Gerhard Kelter et al.
PLOS ONE (2007)
Artesunate inhibits angiogenesis and downregulates vascular endothelial growth factor expression in chronic myeloid leukemia K562 cells
Hui-Jun Zhou et al.
VASCULAR PHARMACOLOGY (2007)
Peroxide bond-dependent antiplasmodial specificity of arternisinin and OZ277 (RBx11160)
Marcel Kaiser et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2007)
Artesunate Induces ROS-Mediated Apoptosis in Doxorubicin-Resistant T Leukemia Cells
Thomas Efferth et al.
PLOS ONE (2007)
Dihydroartemisinin exerts cytotoxic effects and inhibits hypoxia inducible factor-1α activation in C6 glioma cells
Xiao-Jia Huang et al.
JOURNAL OF PHARMACY AND PHARMACOLOGY (2007)
GENECODIS: a web-based tool for finding significant concurrent annotations in gene lists
Pedro Carmona-Saez et al.
GENOME BIOLOGY (2007)
Induction of apoptosis and inhibition of cell migration and tube-like formation by dihydroartemisinin in murine lymphatic endothelial cells
Jun Wang et al.
PHARMACOLOGY (2007)
Case report of a pituitary macroadenoma treated with artemether
Narendra P. Singh et al.
INTEGRATIVE CANCER THERAPIES (2006)
The pharmacokinetics of intravenous artesunate in adults with severe falciparum malaria
Paul N. Newton et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2006)
The transferrin receptor part I: Biology and targeting with cytotoxic antibodies for the treatment of cancer
Tracy R. Daniels et al.
CLINICAL IMMUNOLOGY (2006)
The transferrin receptor part II: Targeted delivery of therapeutic agents into cancer cells
Tracy R. Daniels et al.
CLINICAL IMMUNOLOGY (2006)
The NCI60 human tumour cell line anticancer drug screen
Robert H. Shoemaker
NATURE REVIEWS CANCER (2006)
Dihydroartemisinin enhances radiosensitivity of human glioma cells in vitro
SJ Kim et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2006)
Artemisone - A highly active antimalarial drug of the artemisinin class
RK Haynes et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2006)
Toxic brainstem encephalopathy after artemisinin treatment for breast cancer
LA Panossian et al.
ANNALS OF NEUROLOGY (2005)
Yeast model uncovers dual roles of mitochondria in the action of arternisinin
W Li et al.
PLOS GENETICS (2005)
VisANT: an online visualization and analysis tool for biological interaction data
ZJ Hu et al.
BMC BIOINFORMATICS (2004)
Enhancement of cytotoxicity of artemisinins toward cancer cells by ferrous iron
T Efferth et al.
FREE RADICAL BIOLOGY AND MEDICINE (2004)
Identification of an antimalarial synthetic trioxolane drug development candidate
JL Vennerstrom et al.
NATURE (2004)
Artesunate reduces chicken chorioallantoic membrane neovascularisation and exhibits antiangiogenic and apoptotic activity on human microvascular dermal endothelial cell
HH Chen et al.
CANCER LETTERS (2004)
Inhibitory effects of artesunate on angiogenesis and on expressions of vascular endothelial growth factor and VEGF receptor KDR/flk-1
HH Chen et al.
PHARMACOLOGY (2004)
Transferrin overcomes drug resistance to artemisinin in human small-cell lung carcinoma cells
D Sadava et al.
CANCER LETTERS (2002)
Short tandem repeat profiling provides an international reference standard for human cell lines
JR Masters et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
分享论文
